Cargando…
NAFLD Preclinical Models: More than a Handful, Less of a Concern?
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, cirrhosis, and/or hepatocellular carcinoma. Due to its increasing prevalence, NAFLD is currently a major public health concern. Although a wide variety...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167756/ https://www.ncbi.nlm.nih.gov/pubmed/32046285 http://dx.doi.org/10.3390/biomedicines8020028 |
_version_ | 1783523598114226176 |
---|---|
author | Oligschlaeger, Yvonne Shiri-Sverdlov, Ronit |
author_facet | Oligschlaeger, Yvonne Shiri-Sverdlov, Ronit |
author_sort | Oligschlaeger, Yvonne |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, cirrhosis, and/or hepatocellular carcinoma. Due to its increasing prevalence, NAFLD is currently a major public health concern. Although a wide variety of preclinical models have contributed to better understanding the pathophysiology of NAFLD, it is not always obvious which model is best suitable for addressing a specific research question. This review provides insights into currently existing models, mainly focusing on murine models, which is of great importance to aid in the identification of novel therapeutic options for human NAFLD. |
format | Online Article Text |
id | pubmed-7167756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71677562020-04-21 NAFLD Preclinical Models: More than a Handful, Less of a Concern? Oligschlaeger, Yvonne Shiri-Sverdlov, Ronit Biomedicines Review Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, cirrhosis, and/or hepatocellular carcinoma. Due to its increasing prevalence, NAFLD is currently a major public health concern. Although a wide variety of preclinical models have contributed to better understanding the pathophysiology of NAFLD, it is not always obvious which model is best suitable for addressing a specific research question. This review provides insights into currently existing models, mainly focusing on murine models, which is of great importance to aid in the identification of novel therapeutic options for human NAFLD. MDPI 2020-02-08 /pmc/articles/PMC7167756/ /pubmed/32046285 http://dx.doi.org/10.3390/biomedicines8020028 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Oligschlaeger, Yvonne Shiri-Sverdlov, Ronit NAFLD Preclinical Models: More than a Handful, Less of a Concern? |
title | NAFLD Preclinical Models: More than a Handful, Less of a Concern? |
title_full | NAFLD Preclinical Models: More than a Handful, Less of a Concern? |
title_fullStr | NAFLD Preclinical Models: More than a Handful, Less of a Concern? |
title_full_unstemmed | NAFLD Preclinical Models: More than a Handful, Less of a Concern? |
title_short | NAFLD Preclinical Models: More than a Handful, Less of a Concern? |
title_sort | nafld preclinical models: more than a handful, less of a concern? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167756/ https://www.ncbi.nlm.nih.gov/pubmed/32046285 http://dx.doi.org/10.3390/biomedicines8020028 |
work_keys_str_mv | AT oligschlaegeryvonne nafldpreclinicalmodelsmorethanahandfullessofaconcern AT shirisverdlovronit nafldpreclinicalmodelsmorethanahandfullessofaconcern |